Celularity Announces Closing of Transaction with NexGel
Celularity closed the sale of its biomaterials assets to NexGel for $13.3 million, consisting of $8.3 million in cash and a $5 million convertible note. The company used the transaction to retire nearly $13 million in debt, strengthening its balance sheet and capital position.
Key figures
- Deal Value Usd
- 13300000
- Debt retired
- $13.0 million
- Cash at closing
- $8.3 million
- Convertible note
- $5.0 million
- Potential milestones
- $20.0 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.